Mirvaso 00299-5980
Generic: Brimonidine Tartrate
Product NDC
00299-5980- Manufacturer
- Galderma Laboratories, L.p.
- Dosage Form
- Gel
- Route
- Topical
- Product Type
- Human Prescription Drug
- Marketing Start
- August 23, 2013
- Listing Expires
- December 31, 2026
- Application
- NDA204708
Need to source Mirvaso? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brimonidine Tartrate | 5 mg/g |
Drug Class
Adrenergic alpha-Agonists [MoA]alpha-Adrenergic Agonist [EPC]
Packaging Options(5)
1 TUBE in 1 BLISTER PACK (0299-5980-00) / 2 g in 1 TUBE
2 g in 1 TUBE (0299-5980-02)
30 g in 1 TUBE (0299-5980-30)
1 BOTTLE, PUMP in 1 CARTON (0299-5980-35) / 30 g in 1 BOTTLE, PUMP
45 g in 1 TUBE (0299-5980-45)